Clinical Trials Directory

Trials / Completed

CompletedNCT02538042

Strengthening Instrumental Extinction to Prevent Smoking Relapse (VLNCCue)

Strengthening Instrumental Extinction to Prevent Smoking Relapse

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
87 (actual)
Sponsor
Francis McClernon, Ph.D. · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

The central objective of the project is to evaluate the effect of incorporating smoking related contexts into very low nicotine content (VLNC) cigarette extinction trials on clinically relevant, smoking-related outcomes. Adult smokers interested in quitting smoking (N=80) will be interviewed and trained to take pictures where they smoke cigarettes. Following taking these pictures, participants will then be switched to smoke VLNCs while wearing a 21 mg/d nicotine patch (EXT) for three weeks. During this 3-week treatment period, half of the sample (n=40) will be randomly assigned to undergo six, 60-minute sessions of multiple context extinction (MCE+) during which they will view smoking-related environments and smoke their assigned cigarettes. The remaining 40 participants will undergo control MCE (exposure to nature environments; MCE-) and smoke their assigned cigarettes. At the end of the three weeks, participants will quit smoking and continue to wear the nicotine patch while being followed during a 10-week abstinence period. Participants will also complete a follow-up phone call 6 months after their quit day.

Conditions

Interventions

TypeNameDescription
DRUGNicotine PatchBoth groups will receive nicotine patches (21 mg/d if smoking ≥10 cigs/d or 14 mg/d if smoking \<10 cigs/d) to wear for 3 weeks prior to the quit date. After the quit date, both groups will wear the nicotine patch for 10 weeks. Participants that smoked ≥10 cigs/d will wear a 21 mg/d patch for 6 weeks, a 14 mg/d patch for 2 weeks, and a 7 mg/d patch for 2 weeks. Participants that smoked \<10 cigs/d will wear a 14 mg/d patch for 6 weeks, then step down to a 7 mg/d patch for 4 weeks.
DRUGSPECTRUM Nicotine Research Cigarettes (0.07 mg)For 3 weeks prior to their quit day, participants will switch to smoking SPECTRUM Nicotine Research Cigarettes instead of their usual brand.
BEHAVIORALMCE+During the 3-week, pre-quit period, participants will undergo six, 60 minute sessions during which they will view smoking-related environments and smoke their assigned cigarettes.
BEHAVIORALMCE-During the 3-week, pre-quit period, participants will undergo six, 60 minute sessions during which they will view nature environments and smoke their assigned cigarettes.

Timeline

Start date
2015-10-08
Primary completion
2017-09-08
Completion
2017-09-08
First posted
2015-09-02
Last updated
2018-11-14
Results posted
2018-11-14

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02538042. Inclusion in this directory is not an endorsement.